AML cells express receptors for angiogenic factors, such as VEGFR1 (about 50% of leukemic blasts) and VEGFR2 (about 20% of leukemic blasts); they also secrete angiogenic factors such as vascular endothelial growth factor (VEGF) [23-28]. Here, VEGFA is linked to acute myeloid leukemia.